SCHEMBL3845666

SCHEMBL3845666

Brc1ccc(Oc2ccccc2Br)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 2/20 0.53
SLC6A2 P23975 1/20 0.53
SLC6A3 Q01959 1/20 0.53
ALDH1A1 P00352 5/20 0.46
MAPK1 P28482 4/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
MAPT P10636 1/20 0.46
HTT P42858 1/20 0.46
TDP1 Q9NUW8 2/20 0.43
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
TSHR P16473 2/20 0.39
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
KMT2A Q03164 1/20 0.38
ABCG2 Q9UNQ0 1/20 0.38
NCOA1 Q15788 1/20 0.37
NCOA3 Q9Y6Q9 1/20 0.37
HTR7 P34969 1/20 0.37
HTR6 P50406 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL74839 0.93 ALDH1A1 (0.52) SLC6A4SLC6A2SLC6A3ALDH1A1MAPK1
SCHEMBL3843172 0.91 ALDH1A1 (0.50) SLC6A4SLC6A2SLC6A3ALDH1A1MAPK1
SCHEMBL3839100 0.88 ALDH1A1 (0.58) SLC6A4SLC6A2SLC6A3ALDH1A1MAPK1
SCHEMBL8954758 0.86 LTA4H (0.55) SLC6A4SLC6A2ALDH1A1MAPK1L3MBTL1
SCHEMBL130304 0.86 LTA4H (0.52) SLC6A4SLC6A2SLC6A3ALDH1A1MAPK1
SCHEMBL3898531 0.84 ALDH1A1 (0.49) SLC6A4SLC6A2SLC6A3ALDH1A1MAPK1
SCHEMBL30039490 0.84 ALDH1A1 (0.49) SLC6A4SLC6A2SLC6A3ALDH1A1MAPK1
SCHEMBL4859489 0.84 LTA4H (0.50) SLC6A4SLC6A2SLC6A3ALDH1A1MAPK1
SCHEMBL29477934 0.84 SLC6A4 (0.55) SLC6A4SLC6A2SLC6A3ALDH1A1MAPK1
SCHEMBL18096778 0.84 SLC6A4 (0.55) SLC6A4SLC6A2SLC6A3ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114436868-B Compound and organic electroluminescent device, display device 阜阳欣奕华新材料科技股份有限公司 2024-11-15 CN disclosed
CN-114436868-A Compound, organic electroluminescent device and display device 阜阳欣奕华材料科技有限公司 2022-05-06 CN disclosed
EP-1245638-B1 Composition for insulating film formation JSR CORP (JP) 2009-01-14 EP disclosed
US-6852370-B2 Composition for film formation and material for insulating film formation JSR CORPORATION (JP) 2005-02-08 US disclosed
US-20020172652-A1 Composition for film formation and material for insulating film formation JSR CORPORATION (JP) 2002-11-21 US disclosed
EP-1245638-A1 Composition for insulating film formation JSR Corporation (JP) 2002-10-02 EP disclosed
EP-0341295-B1 PROCESS FOR PRODUCING 4,4'-DIBROMODIPHENYL ETHER GREAT LAKES CHEMICAL CORP (US) 1994-03-16 EP disclosed
EP-0341295-A1 PROCESS FOR PRODUCING 4,4'-DIBROMODIPHENYL ETHER GREAT LAKES CHEMICAL CORPORATION (US) 1989-11-15 EP disclosed
US-4835322-A Process for producing 4,4'-dibromodiphenyl ether GREAT LAKES CHEMICAL CORPORATION (US) 1989-05-30 US disclosed
EP-0129762-A2 Polyphenylene ether resin compositions containing halogenated aromatic compound alone as a flame retardant agent GENERAL ELECTRIC COMPANY (US) 1985-01-02 EP disclosed
US-4042603-A SUBSTITUTED DIBENZOFURAN OR 9-FLUORENONE FROM A DIPHENYL ETHER OR BENZOPHENONE UBE INDUSTRIES, LTD. (JA) 1977-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020172652-A1 Composition for film formation and material for insulating film formation VCL, BMI1, PUF60 SLC6A4 2422/4885SLC6A2 1379/4885SLC6A3 2058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.